CHAPTER 1. INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2. RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3. MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4. MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing the number of blood donations
4.1.2. Growing demand for leukopaks in clinical research
4.1.3. Rising incidence and prevalence of leukaemia
4.2. Market Restraints & Challenges
4.2.1. Stringent donor recruitment criteria
4.2.2. The high cost of therapeutic leukapheresis and leukopaks
4.2.3. The dearth of Skilled Professionals and Low Adoption of Therapeutic
Leukapheresis
4.3. Market Opportunities
4.3.1. Increasing investments in emerging economies
4.3.2. Leukapheresis for the pediatric patient
CHAPTER 5. GLOBAL LEUKAPHERESIS MARKET – BY TYPE
5.1. Leukapheresis Devices
5.1.1. Apheresis Devices
5.1.2. Leukoreduction Filters
5.1.3. Leukapheresis Columns & Cell Separators
5.2. Leukapheresis Disposables
CHAPTER 6. GLOBAL LEUKAPHERESIS MARKET – BY APPLICATION
6.1. Research Applications
6.2. Therapeutic Applications
CHAPTER 7. GLOBAL LEUKAPHERESIS MARKET – BY END USER
7.1. Blood Component Providers and Blood Centers
7.2. Academic and Research Institutes
7.3. Hospitals and Transfusion Centers
7.4. Pharmaceutical and Biotechnology Companies
CHAPTER 8. GLOBAL LEUKAPHERESIS MARKET - BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.2.4. Costa Rica
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Chile
8.3.4. Columbia
8.3.5. Others
8.4. Europe
8.4.1. U.K.
8.4.2. Germany
8.4.3. France
8.4.4. Italy
8.4.5. Spain
8.4.6. Russia
8.4.7. Netherlands
8.4.8. Switzerland
8.4.9. Poland
8.4.10. Others
8.5. APAC
8.5.1. China
8.5.2. Japan
8.5.3. India
8.5.4. South Korea
8.5.5. Australia & New Zealand
8.5.6. Malaysia
8.5.7. Singapore
8.5.8. Others
8.6. Middle East & Africa
8.6.1. UAE
8.6.2. Saudi Arabia
8.6.3. Iran
8.6.4. Iraq
8.6.5. Qatar
8.6.6. South Africa
8.6.7. Algeria
8.6.8. Morocco
8.6.9. Nigeria
8.6.10. Egypt
8.6.11. Others
CHAPTER 9. GLOBAL LEUKAPHERESIS MARKET - COMPANY PROFILES
9.1. Hemacare Corporation
9.2. Fresenius Se & Co. KGaA
9.3. Haemonetics Corporation
9.4. Asahi Kasei Medical Co., Ltd.
9.5. Key Biologics, LLC.
9.6. Stemexpress, LLC.
9.7. ALLCells, LLC.
9.8. Terumo BCT
9.9. Stemcell Technologies, Inc.
9.10. Caltag Medsystems Limited
9.11. Zenbio, Inc.
9.12. Precision for Medicine, Inc.
9.13. PPA Research Group, Inc.
9.14. Macopharma SA
CHAPTER 10. GLOBAL LEUKAPHERESIS MARKET - COMPETITIVE
LANDSCAPE
10.1. Market Share Analysis
10.2. Strategies adopted by top companies
10.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 11. MARKET INSIGHTS
11.1. Industry Experts Insights
11.2. Analysts Opinions
11.3. Investment Opportunities
CHAPTER 12. APPENDIX
12.1. List of Tables
12.2. List of Figures
